VEC.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees...

Stats
Šios dienos apimtis	203 762
Vidutinė apimtis	8.30M
Rinkos kapitalizacija	0.00
EPS	£-0.00834 ( 2019-06-29 )
Last Dividend	£19.00 ( 2021-06-01 )
Next Dividend	£0 ( N/A )
P/E	0.0800
ATR14	£0 (0.00%)

Vectura Group PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Vectura Group PLC Finansinės ataskaitos

Annual	2020
Pajamos:	£190.60M
Bruto pelnas:	£101.40M (53.20 %)
EPS:	£0.188

FY	2020
Pajamos:	£190.60M
Bruto pelnas:	£101.40M (53.20 %)
EPS:	£0.188

FY	2019
Pajamos:	£178.30M
Bruto pelnas:	£95.30M (53.45 %)
EPS:	£-0.0340

FY	2018
Pajamos:	£160.50M
Bruto pelnas:	£98.90M (61.62 %)
EPS:	£-0.143

Financial Reports:

No articles found.

Vectura Group PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Vectura Group PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.35 - Potential for dividend initiation, but uncertain (13.08%)

Information

First Dividend	£6.50	2019-10-14
Last Dividend	£19.00	2021-06-01
Next Dividend	£0	N/A
Payout Date	2021-06-11
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	£25.50	--
Avg. Dividend % Per Year	0.00%	--
Score	2.69	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.35
Div. Directional Score	8.24	--

Next Divdend (Est)
(2025-10-01)

£0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

2.69

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2019	£0	0.00%
2020	£0	0.00%
2021	£0	0.00%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
PAF.L	Ex Dividend Knight	2023-11-30	Annually	16	1.80%
FDM.L	Dividend King	2023-09-21	Semi-Annually	10	2.54%
SVS.L	Dividend Knight	2023-08-31	Annually	32	1.81%
KGH.L	Dividend Knight	2023-08-31	Annually	6	1.23%
CCT.L	Dividend Knight	2023-07-13	Semi-Annually	29	2.15%
RBGP.L	Dividend Junior	2023-05-04	Semi-Annually	6	2.45%
GKP.L	Dividend King	2023-07-06	Quarterly	6	14.75%
ANCR.L	Dividend Knight	2023-06-15	Annually	17	0.88%
TPT.L	Dividend Knight	2023-06-08	Annually	27	2.93%
MATE.L	Dividend Knight	2023-06-29	Quarterly	7	2.31%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.642	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.184	1.200	3.87	4.65	[0 - 0.3]
returnOnEquityTTM	0.254	1.500	8.29	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.59	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	0.923	0.800	9.28	7.42	[0.8 - 2.5]
cashRatioTTM	0.923	1.500	5.99	8.98	[0.2 - 2]
debtRatioTTM	0.00631	-1.500	9.89	-10.00	[0 - 0.6]
interestCoverageTTM	1 314.00	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.0380	2.00	9.99	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0181	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.00771	-1.500	9.97	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.532	1.000	4.47	4.47	[0.2 - 0.8]
operatingProfitMarginTTM	0.689	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	5.90	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.286	0.800	-1.425	-1.140	[0.5 - 2]
Total Score				12.14

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	8.78	1.000	9.21	0	[1 - 100]
returnOnEquityTTM	0.254	2.50	8.90	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0181	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0380	2.00	9.99	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.130	1.000	9.25	0	[0.1 - 0.5]
Total Score				4.35

Vectura Group PLC

Vectura Group Plc engages in the provision of pharmaceutical development. The company is headquartered in Chippenham, Wiltshire and currently employs 453 full-time employees. The firm's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.